SCWORX CORP

Company Overview

SCWorx Corp (WORX) is a small healthcare data and software company that offers a cloud-hosted Single Source of Truth (SSOT) and modular SaaS tools for hospitals and health systems (EMR integration, charge/contract management, analytics, M&A integration and professional services). Its business mix is recurring multi‑year SaaS/subscription fees plus separately billed professional services and one‑time normalization projects, and it relies on third‑party hosting (AWS/Rackspace) and partner/reseller channels. Recent financials show revenue contraction ($2.99M in 2024 vs. $3.80M in 2023), continued losses but narrower net loss, high customer concentration, a small direct headcount (seven employees) and heavy reliance on contractors and third‑party vendors. Management discloses substantial doubt about going concern and has pursued convertible debt and a January 2025 securities purchase agreement to fund growth and sales efforts.

Executive Compensation Practices

Given SCWorx’s small‑cap, cash‑constrained SaaS model, executive pay is likely weighted toward equity and deferred/contingent awards rather than high cash salaries; the 2024 MD&A shows a meaningful reduction in non‑cash stock‑based compensation (down ~$361k), consistent with management managing dilution and expense recognition. Compensation performance levers for executives will tend to be contract renewals, ARR/recurring revenue growth, successful implementations (which convert professional services into steady subscription revenue), gross margins on SaaS/professional services and cash‑flow stabilization to address going‑concern risk. The company’s recent issuance of convertible notes and other financings that created significant non‑cash charges in 2025 increases incentive to structure future pay around financing milestones, retention (to mitigate key‑person risk given tiny headcount) and outcomes tied to successful customer renewals or new enterprise deals. Expect use of option grants, time‑based restricted stock or milestone‑based awards for retention, with periodic adjustments if liquidity remains constrained or if dilution limits are a priority for shareholders.

Insider Trading Considerations

WORX is a low‑liquidity, small‑cap Nasdaq issuer with material financing activity (convertible debt, Jan 2025 securities purchase agreement) and a Nasdaq minimum bid price noncompliance notice — events that commonly trigger insider transactions, registrations, and Form 4 activity; monitor filings for insider participation in financings, option exercises, and secondary sales. Material nonpublic items for this company include contract renewals/expirations (customer concentration), going‑concern financing developments, Nasdaq cure actions or reverse split plans, and any vendor/hosting outages or data/security incidents — insiders must avoid trading on such information and may use 10b5‑1 plans when available. Because officers/directors are Section 16 insiders, short‑swing profit rules and prompt Form 4 disclosure apply; traders should watch for accelerated equity grants, convertible note conversions, warrant issuances and increases in dilution that can depress share value. Finally, the small team and reliance on contractors increase the likelihood that even operational developments (implementations, partner wins/losses) are material, so track insider filings closely around quarterly results and press releases.